Back
Stoke Therapeutics Stock Price Chart

7 Stocks to Consider Immediately (must-see chart)
See the green days for 7 major stocks right here, free of charge
Buy
53
STOK
Stoke Therapeutics
Last Price:
$12.02
Seasonality Move:
-11.98%
7 Day Trial
ALL ACCESS PASS
$
7

ALERT: Q3 Could Be a Pivotal Quarter for Nasdaq Stocks
Click Here to Download Your FREE Stock Report Now-
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and STOK is experiencing selling pressure, which indicates risk of future bearish movement.
Stoke Therapeutics Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 11.67 | Buy |
20-day SMA: | 11.64 | Buy |
50-day SMA: | 10.49 | Buy |
200-day SMA: | 10.62 | Buy |
8-day EMA: | 4.75 | Buy |
20-day EMA: | 2.18 | Buy |
50-day EMA: | 0.92 | Buy |
200-day EMA: | 0.24 | Buy |
Stoke Therapeutics Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 1.7 | Buy |
Relative Strength Index (14 RSI): | 65.97 | Buy |
Chaikin Money Flow: | -343744 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (11.2 - 11.82) | Buy |
Bollinger Bands (100): | (7.63 - 10.95) | Buy |
Stoke Therapeutics Technical Analysis
Jun 25 | Jun 26 | Jun 27 | Jun 30 | Jul 1 | Jul 2 | Jul 3 | Jul 7 | Jul 8 | Jul 9 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | Jul | |||||||||
25 | 26 | 27 | 30 | 01 | 02 | 03 | 07 | 08 | 09 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Stoke Therapeutics Stock
Is Stoke Therapeutics Stock a Buy?
-
Stoke Therapeutics share price is 12.02 while STOK 8-day simple moving average is 11.67, which is a Buy signal.
-
The stock price of STOK is 12.02 while Stoke Therapeutics 20-day SMA is 11.64, which makes it a Buy.
-
Stoke Therapeutics 50-day simple moving average is 10.49 while STOK share price is 12.02, making it a Buy technically.
-
STOK stock price is 12.02 and Stoke Therapeutics 200-day simple moving average is 10.62, creating a Buy signal.
STOK Technical Analysis vs Fundamental Analysis
Buy
53
Stoke Therapeutics (STOK)
is a Buy
Is Stoke Therapeutics a Buy or a Sell?
-
Stoke Therapeutics stock is rated a BuyThe current Stoke Therapeutics [STOK] share price is $12.02. The Score for STOK is 53, which is 6% above its historic median score of 50, and infers lower risk than normal.
Stoke Therapeutics Stock Info
Market Cap:
656.3M
Price in USD:
12.02
Share Volume:
605.6K
Stoke Therapeutics 52-Week Range
52-Week High:
16.15
52-Week Low:
5.35
Buy
53
Stoke Therapeutics (STOK)
is a Buy
Stoke Therapeutics Share Price Forecast
-
What is the Stoke Therapeutics stock price today?The Stoke Therapeutics stock price is 12.02 USD today.
-
Will STOK stock go up or go down?Stoke Therapeutics> share price is forecast to RISE/FALL based on technical indicators
-
Is Stoke Therapeutics overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Stoke Therapeutics is not overvalued.
Is Stoke Therapeutics Stock a Buy?
-
Stoke Therapeutics share price is 12.02 while STOK 8-day exponential moving average is 4.75, which is a Buy signal.
-
The stock price of STOK is 12.02 while Stoke Therapeutics 20-day EMA is 2.18, which makes it a Buy.
-
Stoke Therapeutics 50-day exponential moving average is 0.92 while STOK share price is 12.02, making it a Buy technically.
-
STOK stock price is 12.02 and Stoke Therapeutics 200-day simple moving average is 0.24, creating a Buy signal.
Fundamental Analysis of Stoke Therapeutics
Is Stoke Therapeutics a good investment?
-
Analysts estimate an earnings increase this quarter of $0.07 per share, a decrease next quarter of $0.21 per share, an increase this year of $2.10 per share, and a decrease next year of $2.93 per share.
Technical Analysis of Stoke Therapeutics
Should I short Stoke Therapeutics stock?
-
STOK Moving Average Covergence Divergence (MACD) indicator is 1.7, suggesting Stoke Therapeutics is a Buy
-
Stoke Therapeutics Relative Strength Index (RSI) is 65.97, which suggest Stoke Therapeutics is overbought
-
The Bollinger Bands (25) for Stoke Therapeutics is (11.2 - 11.82), which suggest Stoke Therapeutics is a Buy
-
The Bollinger Bands (100) for Stoke Therapeutics is (7.63 - 10.95), which suggest Stoke Therapeutics is a Buy
* Stoke Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.